C
HZNP

Covestor’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Covestor’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-242
Closed -$28K – 2896
2023
Q3 		$28K Sell
242
-5
-2% -$537 0.02% 1006
2023
Q2 		$26K Sell
247
-11
-4% -$1.16K 0.02% 1035
2023
Q1 		$29K Sell
258
-2,798
-92% -$309K 0.03% 902
2022
Q4 		$348K Buy
3,056
+975
+47% +$81K 0.28% 35
2022
Q3 		$128K Buy
2,081
+1,274
+158% +$89K 0.11% 236
2022
Q2 		$65K Sell
807
-53
-6% -$5.02K 0.05% 651
2022
Q1 		$91K Buy
860
+520
+153% +$50.7K 0.06% 571
2021
Q4 		$37K Buy
+340
New +$37.1K 0.05% 695

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Covestor's HZNP Position: Q4 2023 in Review

Covestor sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 242 shares — an estimated $28K sold.

Covestor first reported a position in HZNP in Q4 2021 and held it in 8 quarters. The position peaked at $348K in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Covestor reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Covestor sold 242 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $28K.
  • Covestor first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 8 quarters.
  • Covestor's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $348K in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Covestor's 13F filing for Q4 2023, filed 9 Feb 2024.